
The pertuzumab biosimilar is set to be commercially available in the third quarter of 2028.
Christina Madison, PharmD, FCCP, AAHIVP, speaks with Ryan Haumschild, PharmD, MS, MBA, to discuss current issues in oncology, including drug shortages and patient access.
On this episode of Public Health Matters, Christina Madison, PharmD, FCCP, AAHIVP, spoke with Ryan Haumschild, PharmD, MS, MBA, to discuss current issues in oncology, including drug shortages and patient access.
Ryan Haumschild, PharmD, MS, MBA, is the director of pharmacy services at Emory Healthcare and Winship Cancer Institute in Atlanta, Georgia.





